<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /opt/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Title: Testosterone increases risk-taking for status but not for money</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2020-04-25">25 April 2020</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Losecaat</forename><surname>Vermeer</surname></persName>
							<email>annabel.losecaat.vermeer@univie.ac.at</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Cognition, Emotion, and Methods in Psychology</orgName>
								<orgName type="department" key="dep2">Faculty of Psychology</orgName>
								<orgName type="laboratory">Neuropsychopharmacology and Biopsychology Unit</orgName>
								<orgName type="institution">University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A S</forename><surname>Boksem</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Rotterdam School of Management</orgName>
								<orgName type="institution">Erasmus University</orgName>
								<address>
									<postBox>PO Box 1738</postBox>
									<postCode>3000 DR</postCode>
									<settlement>Rotterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Gausterer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Cognition, Emotion, and Methods in Psychology</orgName>
								<orgName type="department" key="dep2">Faculty of Psychology</orgName>
								<orgName type="laboratory">Neuropsychopharmacology and Biopsychology Unit</orgName>
								<orgName type="institution">University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">FDZ-Forensisches DNA Zentrallabor GmbH</orgName>
								<orgName type="institution" key="instit2">Medical University of Vienna</orgName>
								<address>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">†</forename><surname>Lamm</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Cognition, Emotion, and Methods in Psychology</orgName>
								<orgName type="department" key="dep2">Faculty of Psychology</orgName>
								<orgName type="laboratory">Neuropsychopharmacology and Biopsychology Unit</orgName>
								<orgName type="institution">University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution" key="instit1">Vienna Cognitive Science Hub</orgName>
								<orgName type="institution" key="instit2">University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department of Cognition, Emotion, and Methods in Psychology</orgName>
								<orgName type="department" key="dep2">Faculty of Psychology</orgName>
								<orgName type="laboratory">Neuropsychopharmacology and Biopsychology Unit</orgName>
								<orgName type="institution">University of Vienna</orgName>
								<address>
									<addrLine>Liebiggasse 5</addrLine>
									<postCode>1010</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Title: Testosterone increases risk-taking for status but not for money</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2020-04-25">25 April 2020</date>
						</imprint>
					</monogr>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.1" ident="GROBID" when="2025-06-29T12:58+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>testosterone</term>
					<term>social status</term>
					<term>risk</term>
					<term>decision making</term>
					<term>dopamine</term>
					<term>genetic polymorphism</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Testosterone has long been thought to increase risk-taking, but evidence supporting this association is mixed. Instead, testosterone&apos;s key role may be to promote status-seeking behaviors. Here, we examined to what extent testosterone administration affects risk preferences for both monetary and social status outcomes, and whether this relationship is moderated by an individuals&apos; social status. Male participants (N=166) experienced high or low status in a competition task and then played two risk tasks; one involving gambles with only monetary outcomes, and another one involving gambles with non-monetary outcomes that influenced their social rank. We found that testosterone (vs. placebo) altered risk preferences for gains and losses in social rank, but not for monetary gains and losses. Specifically, testosterone increased risk-taking to increase social rank in individuals with high, but not low social status. These results demonstrate a context-dependent role of testosterone in regulating risk-taking for social status.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Testosterone is a steroid hormone primarily associated with status-seeking behaviors such as aggression and competition <ref type="bibr" target="#b11">(Eisenegger, Haushofer, &amp; Fehr, 2011)</ref>. In parallel, there is growing interest for its proposed role in non-social behaviors such as risk-taking. A popular lay belief is that testosterone causes excessive risk-taking (e.g. reckless driving, and competition more generally), with news outlets even blaming the hormone for the financial crisis in <ref type="bibr">(e.g. Scientific American, 2009</ref>. To date, the scientific literature has been relatively mixed about whether testosterone actually increases risktaking. A major remaining question is, under which circumstances testosterone causally affects risktaking, and if this depends on whether risk-taking can be a means to achieve higher social status or not.</p><p>Both in the field and laboratory experimental settings (reviewed in <ref type="bibr" target="#b0">Apicella, Carré, &amp; Dreber, 2015;</ref><ref type="bibr" target="#b32">Stanton, 2017)</ref>, testosterone levels correlated with changes in economic decision-making. For example, changes in testosterone predicted increased preference for risky choices involving monetary gains and losses <ref type="bibr" target="#b1">(Apicella, Dreber, &amp; Mollerstrom, 2014)</ref>. Other work found enhanced risk-taking, but only among individuals with high and low baseline testosterone levels <ref type="bibr" target="#b33">(Stanton et al., 2011)</ref>, and testosterone to influence risk-taking only in individuals with low baseline cortisol levels <ref type="bibr" target="#b29">(Mehta, Welker, Zilioli, &amp; Carré, 2015)</ref>. Nonetheless, there have also been reports of null results (e.g., <ref type="bibr" target="#b10">Derntl, Pintzinger, Kryspin-Exner, &amp; Schöpf, 2014)</ref>.</p><p>Of the several investigations on the causal influence of exogenous testosterone on risk-taking, only half reported positive or mixed evidence <ref type="bibr" target="#b7">(Cueva et al., 2015;</ref><ref type="bibr" target="#b19">Goudriaan et al., 2010;</ref><ref type="bibr" target="#b30">Nadler, Jiao, Johnson, Alexander, &amp; Zak, 2017;</ref><ref type="bibr" target="#b35">van Honk et al., 2004;</ref><ref type="bibr" target="#b38">Wu et al., 2016)</ref>, whereas others found no statistically significant effect <ref type="bibr" target="#b4">(Boksem et al., 2013;</ref><ref type="bibr" target="#b39">Zethraeus et al., 2009)</ref>. In sum, both correlational and testosterone administration studies demonstrate that testosterone's influence on risk-taking remains debated.</p><p>Risk-taking may function as a means for attaining higher social status .</p><p>For instance, individuals' relative status has been shown to influence risk-taking in a competition to gain a higher status <ref type="bibr" target="#b15">(Ermer, Cosmides, &amp; Tooby, 2008)</ref>. One proposal is that testosterone may function to enhance risk-taking to attain higher social status, but not or to a lesser degree when risk-taking does not directly serve one's social status.</p><p>Theoretical models of testosterone <ref type="bibr" target="#b2">(Archer, 2006;</ref><ref type="bibr" target="#b26">Mazur &amp; Booth, 1998)</ref> postulate that testosterone fluctuates with social challenges and predicts status-relevant risky behaviors, such as aggression (reviewed in <ref type="bibr" target="#b17">Geniole &amp; Carré, 2018)</ref>, competition <ref type="bibr" target="#b6">(Casto, Edwards, Akinola, Davis, &amp; Mehta, 2020;</ref><ref type="bibr" target="#b24">Losecaat Vermeer et al., 2020;</ref><ref type="bibr" target="#b27">Mehta &amp; Josephs, 2006;</ref><ref type="bibr" target="#b28">Mehta, Son, et al., 2015)</ref>, and social trust <ref type="bibr" target="#b4">(Boksem et al., 2013)</ref>. While some work controlled for individual risk-taking by using a separate nonsocial task <ref type="bibr" target="#b4">(Boksem et al., 2013;</ref><ref type="bibr" target="#b12">Eisenegger, Kumsta, Naef, Gromoll, &amp; Heinrichs, 2017)</ref>, no studies to date tested whether testosterone alters risk-taking with direct status implications, and whether this depends on individuals' social status levels (see <ref type="bibr" target="#b16">Fisk, Miller, &amp; Overton, 2017)</ref>.</p><p>According to the Biosocial Model of Status <ref type="bibr" target="#b26">(Mazur &amp; Booth, 1998)</ref>, changes in testosterone following a win (i.e. equivalent to high status) may reinforce status-enhancing risky behaviors, whereas changes following a loss (i.e. equivalent to low status) may inhibit status-enhancing behaviors. This directly motivated the risk-for-status hypothesis in the present investigation. Extending on previous theories of the effects of testosterone, we predicted that high testosterone in individuals with high social status increases risk-taking when this could serve attaining higher status, whereas high testosterone in individuals with low social status should not, or even reduce risk-taking that can impact their social status. Importantly, these considerations would also predict that testosterone only influences risk-taking when it has direct implications for social status, and not when risk-taking has no implications to status.</p><p>To test this, we performed a double-blind placebo-controlled administration study in which men received either testosterone or placebo, and played a competition task where their social status was manipulated to be either high or low, indicated via a ranking. Following the competition, participants played two gambling tasks. The first task only contained monetary gain-loss gambles with no impact to their social rank. The second task contained gambles with gain-loss outcomes in social rank without monetary incentives, to assess risk-taking for social status independent of monetary reward. The present study is thus the first to simultaneously manipulate testosterone and status to test their effects on risk-taking, while additionally dissociating risk preferences for money and for status.</p><p>Testosterone effects on status-seeking behaviors may depend on the functioning of the testosterone-binding androgen receptor <ref type="bibr" target="#b12">(Eisenegger et al., 2017;</ref><ref type="bibr" target="#b18">Geniole et al., 2019;</ref><ref type="bibr" target="#b24">Losecaat Vermeer et al., 2020)</ref>, and testosterone's actions on the striatal dopaminergic reward system (Losecaat <ref type="bibr" target="#b25">Vermeer, Riečanský, &amp; Eisenegger, 2016;</ref><ref type="bibr" target="#b28">Mehta, Son, et al., 2015)</ref>. We thus explored whether effects of testosterone on risk-taking are also moderated by individual genetic differences, focusing on polymorphisms related to the androgen receptor, and striatal dopamine. The efficiency of the androgen receptor is negatively correlated with the cytosine-adenine-guanine (CAG)-repeat length in exon 1 of the androgen receptor gene <ref type="bibr" target="#b40">(Zitzmann &amp; Nieschlag, 2003)</ref>, therefore we determined CAGrepeat length for each participant. Moreover, testosterone increases dopamine and activity in the ventral striatum, in animals <ref type="bibr" target="#b8">(de Souza Silva, Mattern, Topic, Buddenberg, &amp; Huston, 2009)</ref> and humans <ref type="bibr" target="#b21">(Hermans et al., 2010)</ref>. We thus measured a polymorphism related to DAT1 , the dopamine transporter, as a proxy for striatal dopamine.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Method</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Participants</head><p>One hundred-seventy-three male volunteers participated in the study. This sample size was directly informed by previous high-profile single-dose testosterone administration studies on status-relevant behavior and risk-taking (e.g. <ref type="bibr" target="#b4">Boksem et al., 2013;</ref><ref type="bibr" target="#b5">Carré et al., 2017;</ref><ref type="bibr" target="#b13">Eisenegger, Naef, Snozzi, Heinrichs, &amp; Fehr, 2010)</ref>, and work on status-seeking behavior in relation to CAG-repeat polymorphism <ref type="bibr" target="#b12">(Eisenegger et al., 2017)</ref>. Participants were pre-screened and had no history of psychiatric, neurological, or endocrine disease, nor were currently using or had been regular users of marijuana or any psychotropic drugs and corticosteroids, and had not taken part in a medical study in the four weeks preceding the study. The pharmacokinetics of testosterone gel administration has been established in men <ref type="bibr" target="#b14">(Eisenegger, von Eckardstein, Fehr, &amp; von Eckardstein, 2013)</ref>, therefore our sample only included men. Seven participants were excluded; six participants due to a technical error, which resulted in either a partial or complete loss of their data (n=2), or in incorrect rank presentation (n=4), and one participant who was unintentionally included twice in the study. The final sample consisted of 166 men (Placebo (N=84): M=24.55 years, SD=3.64; Testosterone (N=82): M=24.38 years, SD=3.33). All participants provided consent and were financially compensated for completing the study. The study procedure was performed in accordance with the Declaration of Helsinki and approved by the Medical Ethics Committee of the University of Vienna (1918/2015).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>General procedure</head><p>Participants arrived to the lab on two separate days. On the first day, participants filled out a series of personality questionnaires including demographics, provided DNA for genotyping, and were measured for their Body Mass Index (BMI) and body fat using a body composition monitor (Omron BF51). At the end of the day, participants received 10 Euro endowment in advance to enhance the feeling of ownership of this money which they could later lose in the subsequent experiment. They were instructed that this endowment was theirs to keep and to pay for any losses during the risk task on the second test day.</p><p>The second day, at 10:00 a.m. participants arrived to the lab in groups of nine. After participants provided consent and received instructions of the procedure, they completed additional questionnaires assessing self-reported mood and personality traits such as trait dominance (16-PF-R, <ref type="bibr" target="#b31">Schneewind &amp; Graf, 1998)</ref>, which has previously shown to moderate effects of testosterone on statusseeking, mainly in individuals with high trait dominance <ref type="bibr" target="#b28">(Mehta, Son, et al., 2015)</ref>. Twenty minutes after arrival, participants provided the first saliva sample (t0), to assess baseline hormone concentrations. Next, participants were administered with testosterone or placebo by random assignment (section Drug administration). Participants waited in the lab for two hours to allow the drug to reach peak level, but did not interact with others. Two-hours post-administration, participants completed a second mood questionnaire to control for a potential confound of treatment, see Supplementary Online Material (SOM), and provided their second saliva sample (t120). To minimize diurnal hormone variability, the behavioral testing occurred from 1:00-3:00 p.m. Testing included a competition paradigm with a brief post-task questionnaire <ref type="bibr" target="#b24">(Losecaat Vermeer et al., 2020)</ref>, followed by the risk paradigm and then one other task which is unrelated to the question reported here. At the end, we assessed participants' beliefs about whether they believed they had received testosterone or placebo via a binary choice, and their confidence about their answer on a scale from 0-100 ( <ref type="table" target="#tab_0">Table 1</ref>).</p><p>After that we paid them for participation and paid out any gains from the risk task. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Task procedure</head><p>Prior to the risk task, we experimentally induced high or low social status in participants via a competition task <ref type="bibr" target="#b24">(Losecaat Vermeer et al., 2020)</ref>, which included nine players and lasted for approximately 60 minutes. In brief, the competition paradigm entailed a reaction time task, in which participants had to respond as fast as possible to a target on screen appearing at random intervals.</p><p>The faster participants responded, the more points they could earn. Participants repeatedly played against each other and based on their score on each round they saw they obtained either a high (varying between 1-4) or low (varying between 6-9) position in a ranking list. Unbeknownst to participants, in reality their ranks were based on random assignment. Participants sat in the same room, in individual cubicles to make the competitive task more realistic.</p><p>Following the competition, participants performed the risk paradigm, consisting of two tasks. In the first task, participants performed a series of gambles involving monetary gains and losses. In the second task, participants performed a series of gambles involving social gains and losses (increases or decreases in the social ranking), without monetary outcomes. Participants were briefly reminded about their final position in the ranking resulting from the previously completed competition task, before receiving instructions and practice trials to perform the monetary risk task <ref type="figure" target="#fig_0">(Fig. 1a)</ref>. Next, for the status risk task, we explicitly instructed participants that the outcome of the upcoming gambles would only affect their rank position by adding or deducting points from their score achieved in the competition, and could result in gain or loss in rank respectively. To compare high and low ranked participants, we presented participants with a new ranking consisting of players whom had previously participated in the experiment and had the same rank position. Specifically, both high and low-ranked participants were compared to eight participants with an identical rank position to themselves. In this new ranking, the name of each player and their score was shown, including the difference in points compared to the participant, who was placed in the middle (i.e. 5 th ). This was done to provide the opportunity to enhance and reduce further status by gaining or losing position in the ranking based on the outcome of these gambles. This new rank list was shown at all times at the top of the screen <ref type="figure" target="#fig_0">(Fig.    1b</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Risk paradigm</head><p>We developed a novel paradigm consisting of a monetary and status risk task in fixed order. For both, participants had to choose whether to accept or reject a gamble with an equal probability to win or lose. If participants decided to reject the gamble they would simply not gain or lose anything. No immediate feedback was given to avoid carry-over effects of the outcome to the next trial. At the end of the experiment, one gamble of each task was randomly chosen and played in case the participant had chosen to accept the gamble. After competition participants saw their name in the rank list. Followed by this rank list, participants could decide to accept the gamble with equal probability to win or lose or reject it (i.e. choose € 0). (b) Example of a status risk trial of a high ranked participant. At the beginning, the participant saw a new ranking, consisting of players who had previously participated in the experiment and ended up in the participants' rank category (i.e. here high). While the participant's precise rank is number one, his performance is ranked 5 th among the other players of his rank category (i.e. whom also ended up as number one in their competition). Participants could decide to accept or reject gambles with equal probability to win or lose status points for rank position. No immediate feedback was provided in both tasks.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>I. Monetary risk task</head><p>Sixteen trials, each containing a monetary gain/loss gamble were presented. The gambles had a fixed gain of € 12 and a loss ranging from € -1 to € -16, with steps of € 1 <ref type="figure" target="#fig_0">(Fig. 1a)</ref>. On each trial, participant's rank was shown at the top of the screen. However, participants were instructed that the outcome of these gambles only had consequences for their monetary endowment of € 10, but not for their status in the experiment.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>II. Status risk task</head><p>Sixteen trials, each containing a gain/loss gamble in terms of points were presented. The gain and loss points ranged from 30 to 120 (in steps of 30 points) and had consequences for participants' position in the rank list. Points would be either added or subtracted from the participants' score depending on the gain or loss outcome and determined their final social status in the experiment. On each trial, the players' rank, including their score and difference in points to the participant's score was shown, for the participants to see the potential impact a specific gamble would have on their position on the ranking. The task also contained two gambles with an expected value of zero, but one with high and one with low variance (i.e. risk level). The high variance gamble provided a gain or loss of 120 points (i.e. gain/loss of 4 positions, resulting in first or last place), whereas the low variance gamble provided a gain or loss of 30 points (i.e. gain/loss of 1 position, resulting in 4 th or 6 th place respectively). There were also two catch trials to check if participants paid attention in which with an equal probability one could win 1 position or lose none, or lose 1 position or win none. Catch trials were excluded from analysis. The outcomes of the status gambles had no monetary consequences throughout, neither immediately nor later in the experiment.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Drug administration</head><p>We randomly assigned participants to receive a single dose of 150 mg testosterone <ref type="bibr">(Testogel®,</ref><ref type="bibr">N=82)</ref> or placebo gel (N=84) in a double-blind procedure. The gel was topically applied to chest, shoulders and upper arms by a male research assistant. The pharmacokinetics of this dosage and administration technique have previously been established in men <ref type="bibr" target="#b14">(Eisenegger et al., 2013)</ref>. This showed testosterone levels to peak 3 h post-administration with a significant increase after 2 h. Therefore, behavioral testing commenced 2 h post-administration, with the risk task 195 min post-administration. Recent work using larger samples and same dosage observed a significant increase in testosterone levels as fast as 1 h post-administration (see e.g. <ref type="bibr" target="#b5">Carré et al., 2017)</ref>. Notwithstanding, evidence of these studies when taken together suggest that testosterone levels were still sufficiently high in our testing window.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Hormonal assays</head><p>Hormone samples were collected via passive drool into a 2 mL polypropylene vial and stored at -30 degrees Celsius. Saliva samples were analyzed for testosterone and hydrocortisone with liquid chromatography tandem mass spectrometry (LCMS/MS) (see SOM for details). Saliva values were winsorized based on three median absolute deviations from the median and log-transformed. <ref type="table" target="#tab_0">Table 1</ref> shows baseline hormone concentrations (t0) did not differ between treatment groups, while testosterone concentration after administration (t120) was significantly increased in the testosterone vs. placebo group, confirming our manipulation was successful.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Genotyping</head><p>DNA was collected using sterile cotton buccal swabs (Sarstedt AG, Germany), and purified applying the did not differ in mean CAG-repeat length (t(161.32) = 0.72, p = .474). For the DAT1 VNTR polymorphisms, 9/10-repeat carriers (9/10R: 34%; testosterone n=29 placebo n=27) and 10/10-repeat carriers (10/10R: 57%; testosterone n=48, placebo n=46) occurred most in our sample (see also SOM).</p><p>Therefore we used these two genotypes in the analyses, with 10/10-Repeat carriers assumed to have higher DAT, expression and hence lower striatal dopamine than 9/10-Repeat carriers .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p>To assess whether testosterone administration alters risk-taking, we ran a generalized mixed effects model on the decision to accept or reject the gamble, using lme4 <ref type="bibr" target="#b3">(Bates, Mächler, Bolker, &amp; Walker, 2015)</ref>  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Social rank influences monetary risk-taking, independent of testosterone</head><p>Participants with a low rank position showed increased risk-taking for monetary gambles as compared to those with high rank (low rank M = 35.7%, 95% CI = [21.9; 52.4], high rank M = 13.8%, 95% CI = [6.9; 23.5], p=.007, <ref type="table" target="#tab_3">Table 2</ref>, <ref type="figure" target="#fig_2">Fig. 2a</ref>). As shown in  <ref type="figure" target="#fig_2">Fig 2b)</ref>. Participants accepted more gambles with increasing expected value <ref type="figure" target="#fig_2">(Fig. 2c</ref>), but this was not significantly moderated by testosterone or the participant's rank <ref type="table" target="#tab_3">(Table 2)</ref>.</p><p>Trait dominance, baseline cortisol and individual polymorphisms of CAG-repeat and DAT1</p><p>genotypes, related to androgen function and dopamine, did not interact with drug or rank to predict risk-taking (see SOM) 1 .  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Testosterone increases risk-taking for status outcomes in individuals with high social status</head><p>Testosterone influenced risk-taking for status depending on participants' rank ( <ref type="table" target="#tab_3">Table 2)</ref>, such that testosterone (vs. placebo) increased risk-taking in participants with a high rank (OR = 3.85, 95% CI = [1.36, 10.92], z = 2.10, p = .036), but not in participants with a low rank (OR = 0.55, 95% CI = [0.20, 1.49], z = -1.07, p = .285, <ref type="figure" target="#fig_3">Fig. 3a</ref>). Rank had a similar effect on risk-taking for status as on risk for money, but this just failed to reach significance (p=.081). Participants accepted more gambles with increasing expected value, though no interaction with drug or rank was observed ( <ref type="table" target="#tab_3">Table 2</ref>, <ref type="figure" target="#fig_3">Fig. 3b</ref>). Baseline cortisol, trait dominance, CAG-repeat and DAT1 polymorphisms did not interact with drug and rank to predict risk-taking 2 . Despite a nonsignificant interaction, when observing the data of high and low cortisol groups (based on median split), the conditional effect of testosterone seemed more pronounced in individuals with low baseline cortisol (for details see SOM The main drug x rank interaction changed to marginal significance when including trait dominance (p=.056) or DAT1 (p=.081), but drug x rank interaction was significant in all other models. Importantly, including all four as covariates in one model demonstrated that the drug x rank interaction effect was robust (p=.024, see SOM).</p><p>testosterone (vs. placebo) appearing to increase risk-taking in 10/10-carriers, and reduce risk-taking in 9/10-carriers.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>In the current study we investigated whether exogenous testosterone influenced risk-taking for choices that could alter the individual's social status level, and for choices with pure monetary outcomes, and whether this was dependent on the individual's current social status (i.e. high or low rank). This was mainly motivated by previous mixed results regarding the influence of testosterone on risk-taking, which had not accounted for the potentially important moderating role of social status.</p><p>Based on prevailing models and research on testosterone function and status-seeking <ref type="bibr" target="#b2">(Archer, 2006;</ref><ref type="bibr" target="#b26">Mazur &amp; Booth, 1998)</ref>, we formulated a risk-for-status hypothesis that predicted testosterone to influence risk-taking when this could serve to attain or maintain high social status. Conversely, this hypothesis predicted that testosterone would not (or less so) influence risk-taking that does not provide an opportunity to improve social status (e.g. gambling to only gain money).</p><p>Results confirmed our risk-for-status hypothesis. Exogenous testosterone (vs. placebo) enhanced risk-taking for status in individuals with high social rank, but not in individuals with low social rank.</p><p>Importantly, monetary risk-taking was unaffected by testosterone administration. Our findings crucially add to previous theories and studies on testosterone and status-seeking <ref type="bibr" target="#b11">(Eisenegger et al., 2011)</ref>, by showing that testosterone influenced risk preferences for options with a possible impact to social status in men with a high social rank, but not for options with monetary outcomes without direct status consequences.</p><p>Our findings are of relevance for previous research reporting an overall positive but weak association of testosterone and monetary risk-taking <ref type="bibr" target="#b7">(Cueva et al., 2015;</ref><ref type="bibr" target="#b19">Goudriaan et al., 2010;</ref><ref type="bibr" target="#b30">Nadler et al., 2017;</ref><ref type="bibr" target="#b35">van Honk et al., 2004;</ref><ref type="bibr" target="#b37">Welker, Roy, Geniole, Kitayama, &amp; Carré, 2019)</ref>. Besides differences in methodologies and sex/gender of the samples (previous work mainly used female participants), most of the studies have not manipulated the relative social status or accounted for the implications for one's social status as a contextual factor in their design and analysis. Therefore, one possible reason for the previously reported inconsistencies in the literature for testosterone and risk-taking is whether individuals could influence their social status through risk-</p><p>taking. In the current study, we explicitly told participants that the monetary gambles would not influence their status level, thereby excluding any perceived challenge or opportunity to improve status. By combining a pharmacological intervention with a risk task containing gambles with status outcomes, we showed that the social implications of choices are an important moderator of testosterone function in risk-taking. We therefore recommend future studies to consider social status in their design and analysis, to further elucidate testosterone's role in risk-taking.</p><p>Low social status has in previous studies been associated with increased monetary risk-taking <ref type="bibr" target="#b36">(Welker, Goetz, &amp; Carré, 2015)</ref>. Likewise, we found increased risk-taking for monetary gambles in individuals with an experimentally manipulated low compared to high social status. Importantly, their status level was irrelevant to the choices at hand. Previous research for monetary choices has shown that people typically avoid risk following a gain, but take risk following a loss, even when these prior gain and loss outcomes were unrelated to the current choice (Losecaat <ref type="bibr" target="#b22">Vermeer, Boksem, &amp; Sanfey, 2014;</ref><ref type="bibr" target="#b34">Tversky &amp; Kahneman, 1981)</ref>. Relatedly, the anticipation of a social loss increased risk-taking (i.e. overbidding) in an experimental auction <ref type="bibr" target="#b9">(Delgado, Schotter, Ozbay, &amp; Phelps, 2008)</ref>. Our results add to these findings, demonstrating that a high or low social status influenced risk preferences in a similar direction as previously experienced monetary losses. Importantly, this was the case even though status information had no relevance to the decision.</p><p>Previously identified moderators of testosterone (i.e. trait dominance, baseline cortisol, CAGrepeat) did not influence effects of testosterone and rank on risk-taking in the present experiment.</p><p>Although we found no statistical interaction with basal cortisol, applying a median split, the conditional effect of testosterone on risk-raking for status tends to be more pronounced in individuals with low cortisol, consistent with predictions of the dual-hormone hypothesis . In contrast to previous work on aggression and competition <ref type="bibr" target="#b18">(Geniole et al., 2019;</ref><ref type="bibr" target="#b24">Losecaat Vermeer et al., 2020)</ref>, we found no association between high androgen receptor sensitivity to testosterone (CAGrepeat) and status-driven risk-taking. DAT1-genotype (hypothesized to affect striatal dopamine availability) influenced risk-taking for status depending on drug administration. While risk-taking was significantly different between DAT1-genotype individuals under placebo, testosterone administration appeared to reverse this effect. Testosterone increased risk-taking in 10/10R-carriers (i.e. lower endogenous dopamine), and to a smaller degree reduced risk-taking in 9/10R-carriers (i.e. higher endogenous dopamine), although this was nonsignificant at post-hoc level. Previous research demonstrated increased striatal activity during reward anticipation following testosterone administration, specifically in low intrinsically motivated women <ref type="bibr" target="#b21">(Hermans et al., 2010)</ref>. Consistent with this, our findings may suggest that testosterone acts on striatal dopamine pathways to motivate risk-taking when anticipating reward of a potential status gain, specifically in those with low baseline dopamine availability. Future studies are required to replicate and test if this relation holds using larger samples.</p><p>It is important to note that, first, our sample only included men because the pharmacokinetics of the testosterone gel is only known in men. Although sex/gender differences for risk-taking are thought to be small (for review see <ref type="bibr" target="#b16">Fisk et al., 2017)</ref>, future research will be required to test whether our effects generalize to females. Second, to compare high and low-ranked individuals on risk preferences for identical risk choices and status outcomes (i.e. magnitudes, change in positions), high and low-ranked participants were placed in the middle of the new hierarchy containing only players of the same rank category. One possibility is that this induced an unstable hierarchy and a perceived small loss (gain) in status in the high (low) ranked participants. Consequently, testosterone may have reinforced risktaking in the high-ranked participants to "redeem" their top position, but inhibited risk-taking in the low-ranked to secure the middle position and avoid further status loss, consistent with previous findings (Losecaat <ref type="bibr" target="#b24">Vermeer et al., 2020)</ref>.</p><p>Concluding, exogenous testosterone increased risk-taking for status, but not for options without direct status implications, in men with high but not low social status. These findings provide important insight for research in the field and theoretical models of testosterone in risk-taking as a strategy for status-seeking.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplementary online material</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mood</head><p>Drug administration did not influence self-reported mood, alertness and calmness (multidimensional mood questionnaire, <ref type="bibr" target="#b43">Steyer, Schwenkmezger, Notz, &amp; Eid, 1994</ref>) (all F values &lt; 1). From pre-to postadministration alertness decreased (F(1,164) = 9.77, p =.002), calmness increased (F(1,164) = 10.97, p =.001), but participant's mood did not statistically change (F(1,164) = 2.11, p =.148).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Hormone analysis</head><p>Saliva samples analyzed for testosterone and hydrocortisone using liquid chromatography tandem Poroshell 120 EC-C18 was used for chromatographic separation under reversed phase conditions. For the internal standard preparation and internal standard mixture was prepared containing 2,3,4-13C3-Hydrocortisone; 2,3,4-13C3-Testosterone, 2,4,16,16,17-d5-17b-Estradiol and 2,4,16,16-d4-Estron with a final concentration of 5ng/mL each. Samples were prepared by adding 100 µl internal standards (5 ng/mL) to 500µl plasma or salvia and the steroids were extracted using 4 mL MTBE. After 10 minutes overhead shacking, samples were centrifuged for 5 minutes at 3000 rpm and the top MTBE layer was transferred to a test tube. MTBE was evaporated using a centrivap concentrator at 40°C (Labconco).</p><p>The residual sample was then re-dissolved in methanol and analyzed by LC-MS/MS.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Genotyping</head><p>Buccal swabs were collected using sterile cotton swabs (Sarstedt AG, Germany) and stored at room temperature. DNA was extracted using the QIAamp DNA Mini kit (Qiagen, Hilden, Germany) following the kit's protocol: "DNA Purification from Buccal Swabs" and eluted in a final volume of 50 μL of QIAamp buffer AE (Qiagen, Hilden, Germany). Human DNA was quantified using the Applied Biosystems (AB) 7500 real-time PCR system (Thermo Fisher Scientific, Waltham, MA) and the Quantifiler HP (Human Plus) Quantification Kit (AB) following manufacturer's recommendations. Both, androgen receptor (AR)CAGn and DAT1 VNTR were simultaneously co-amplified in a single tube reaction. Accordingly, template DNA (10 ng per sample) was subjected to 35 cycles of PCR amplification performed in a total volume of 25 µL consisting of 1 ´ GeneAmp PCR Buffer (AB), 0.25 mM each dNTP, 0.5 U AmpliTaq Gold Polymerase (AB) and target specific primers (including fluorescently-labeled forward primers, details are provided in <ref type="table" target="#tab_0">Table S1</ref>). The following thermal protocol was applied using the Veriti 96-well thermal cycler (AB): 35 cycles at 95 °C for 30 seconds, 55 °C for 1 minute, and 72 °C for 1 minute. Before the first cycle, an initial denaturation (95 °C for 5 minutes) was included, and the last cycle was followed by a final extension step at 72 °C for 45 minutes. Aliquots of PCR products were diluted with Hi-Di formamide (AB), mixed with internal lane standard LIZ 600 v.2 (AB) and separated on the ABI 3500 Genetic Analyzer applying standard conditions. The number of repeats predicted by the GeneMapper ID-X software (AB) was in full agreement to the actual repeats determined by direct sequencing of PCR products using the BigDye Terminator Sequencing Kit v3.1 (AB) in selected DNA samples. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Moderators</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Baseline cortisol</head><p>The model included 158 participants, as some samples (n=8) were not analyzable due to low quality or too little saliva. As shown in <ref type="table">Table S3</ref>, baseline cortisol did not interact with drug or rank. The effect of rank when gambling for money was marginally significant (p=.061). For status, the conditional effect of testosterone and rank remained significant (p=.024). Although a nonsignificant drug x rank x cortisol interaction for status, when applying a median split on cortisol the effect of testosterone in the highranked group appears to be more pronounced among low baseline cortisol individuals <ref type="figure" target="#fig_0">(Fig. S1</ref>). <ref type="figure" target="#fig_0">Figure S1</ref>. Risk-taking for status outcomes, split by rank and baseline cortisol (based on median split). Every dot represents participants' mean. Error bars represent 95% CI. Asterisks indicate significant difference between drug (** p &lt; .01).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Trait dominance</head><p>As shown in <ref type="table">Table S3</ref>, trait dominance did not influence risk-taking for money nor for status, nor did it interact with drug or rank. The main effect of rank when gambling for money remained significant (p=.027). For status, the conditional effect of testosterone and rank reduced to marginal significance (drug x rank, p=.056).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CAG-repeat length</head><p>As shown in <ref type="table">Table S3</ref>, CAG-repeat length did not influence risk-taking for money nor for status, nor did it interact with drug and rank. The main effect of rank when gambling for money (p=.018), and the drug x rank interaction for status (p=.029) remained significant.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DAT1 genotype</head><p>We included data from the 10/10 (testosterone n=48, placebo n=46) and 9/10-carriers (testosterone n=29, placebo n=27), as they represented the largest sample (total n=150), similar to other work <ref type="bibr" target="#b14">(Eisenegger et al., 2013;</ref>. Sixteen participants not included consisted of 9/9-carriers (testosterone n=3, placebo n=8), 10/11-carriers (testosterone n=2, placebo n=2), and one 9/11-carrier (placebo).</p><p>As shown in <ref type="table">Table S3</ref>, DAT1 genotype did not influence risk-taking for money nor for status, nor did it interact with drug and rank. The main effect of rank when gambling for money was marginal significant (p=.051).</p><p>For status, DAT1 interacted with drug to predict risk-taking (p=.035). Although not reaching statistical significance at post-hoc comparisons, decomposing the interaction suggest that 10/10carriers with testosterone (vs. placebo) were almost twice more likely to take risk (OR = 1.97, SE=0.85, 95% CI = [0.85;4.59], z=1.57, p=.116), whereas 9/10-carriers with testosterone (vs. placebo) seem 56% less likely to take risk (OR=0.44, SE=0.25, 95% CI = [0.15; 1.32], z = -1.47, p=.143). Including DAT1 resulted in a marginal significant testosterone by rank effect (p=.081).</p><p>Importantly, when including baseline cortisol, dominance, CAG-repeat and DAT1 as covariates in one model, the conditional effect of testosterone and rank on risk-taking for status was significant (OR=0.67, 95% CI = [0.47,0.95], z = -2.25, p=.024), whereas the main effect of rank for monetary gambles seemed less robust (z = -1.51, p = .130). To note, this model could only be analyzed on a subset of the sample (n=142), which reduced statistical power.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc>Risk paradigm. (a) Example of a monetary risk trial of a high ranked participant.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc>QIAamp DNA Mini kit (Qiagen, Germany). CAG-repeat and DAT1 VNTR polymorphisms were investigated by multiplex PCR with fluorescent-dye-labeled primers and capillary electrophoresis (detailed in SOM). Treatment groups(Testosterone M = 22.11, SD = 3.12, Placebo M = 22.44, SD = 2.80)     </figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 .</head><label>2</label><figDesc>Mean (raw) proportion risk-taking for monetary outcomes. (a) Risk-taking for low compared to high rank category. Every dot represents participants' mean. (b) Risk-taking by drug group (testosterone or placebo) of high and low rank showed no significant interaction. (c) Risk-taking by expected value of the gamble (x-axis, range -2 to 5.5), for drug and rank. The horizontal line represents the point of indifference (i.e. the expected value where proportion of gambling is 0.50). Testosterone had no statistical significant effect on risk-taking by rank and expected value. Error bars and shaded bands represent 95% confidence intervals. Asterisks indicate a significant difference between rank (** p &lt; .01).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 3 .</head><label>3</label><figDesc>Mean (raw) proportion risk-taking for status. (a) Risk-taking for each drug group (testosterone or placebo) of high or low rank. Testosterone (vs. placebo) increased risk-taking in participants of high rank, but not low rank. Every dot represents participants' mean. (b) Risk-taking by expected value of the gamble (x-axis), for drug and rank. Expected value influenced risk-taking, but not differentially for drug or rank. The horizontal line represents the point of indifference (i.e. the expected value where proportion of gambling is 0.50). Error bars and shaded bands represent 95% confidence intervals. Asterisks indicate a significant difference between drug (* p &lt; .05).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head></head><label></label><figDesc>mass spectrometry (LCMS/MS), with an Agilent 6460 with electrospray ionization in positive mode coupled to a 1290 UHPLC system. Collision energy was optimized for specific MRM transitions of Hydrocortisone (363.2/121.1 m/z; 363.2/91.1 m/z), Testosterone (289.2/109.1; 289.2/97.1 m/z), 2,3,4-13C3-Hydrocortisone (366.2/124 m/z) and 2,3,4-13C3-Testosterone (292.2/100 m/z). Agilent</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 . Descriptives by treatment (Placebo, Testosterone) Placebo</head><label>1</label><figDesc></figDesc><table><row><cell></cell><cell></cell><cell>(N=84)</cell><cell></cell><cell cols="3">Testosterone (N=82)</cell><cell>Statistics</cell><cell></cell></row><row><cell></cell><cell>n</cell><cell>M</cell><cell>SD</cell><cell>n</cell><cell>M</cell><cell>SD</cell><cell cols="2">t-value p-value</cell></row><row><cell>Age (years)</cell><cell>84</cell><cell>24.55</cell><cell>3.64</cell><cell>82</cell><cell>24.38</cell><cell>3.33</cell><cell>0.314</cell><cell>.754</cell></row><row><cell>BMI</cell><cell>80</cell><cell>24.27</cell><cell>3.35</cell><cell>82</cell><cell>24.12</cell><cell>2.69</cell><cell>0.331</cell><cell>.741</cell></row><row><cell>Trait Dominance</cell><cell>84</cell><cell>42.52</cell><cell>24.17</cell><cell>82</cell><cell>45.82</cell><cell>25.78</cell><cell>-0.849</cell><cell>.397</cell></row><row><cell>Testosterone log (ng/mL) -t0</cell><cell>82</cell><cell>0.08</cell><cell>0.36</cell><cell>77</cell><cell>0.05</cell><cell>0.43</cell><cell>0.447</cell><cell>.656</cell></row><row><cell>Testosterone log (ng/mL) -t120</cell><cell>84</cell><cell>0.33</cell><cell>0.49</cell><cell>80</cell><cell>3.63</cell><cell>1.53</cell><cell>-18.48</cell><cell>&lt;.001</cell></row><row><cell>Cortisol log (ng/mL) -t0</cell><cell>82</cell><cell>0.60</cell><cell>0.59</cell><cell>76</cell><cell>0.58</cell><cell>0.70</cell><cell>0.269</cell><cell>.789</cell></row><row><cell>Cortisol log (ng/mL) -t120</cell><cell>84</cell><cell>-0.18</cell><cell>0.61</cell><cell>80</cell><cell>-0.15</cell><cell>0.60</cell><cell>-0.284</cell><cell>.777</cell></row><row><cell>Drug belief (%)</cell><cell>84</cell><cell>0.24</cell><cell>0.43</cell><cell>82</cell><cell>0.23</cell><cell>0.42</cell><cell>0.096</cell><cell>.923</cell></row><row><cell>Drug belief confidence (0-100%)</cell><cell>84</cell><cell>56.40</cell><cell>25.24</cell><cell>82</cell><cell>55.39</cell><cell>26.39</cell><cell>0.253</cell><cell>.801</cell></row></table><note>Note: for some comparisons n slightly differs from the total N of each group, i.e. some saliva samples were unanalyzable, and four BMI scores of the placebo group were not recorded. Drug belief (%)= percentage of participants who believed they had received testosterone, t0= baseline, t120= post-administration.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head></head><label></label><figDesc>in the R statistical software package(version 3.4.3, R Development Core Team, 2017). The model included between-subject predictors (at level two) for Drug (testosterone, placebo) and Rank (high, low), and a within-subject predictor (at level one) for Expected Value of the gamble, including their interactions. The model also included a random intercept for participant including by-participant random slopes for expected value of the gambles to account for repeated observations and variability among participants. We ran this model separately on the behavior for the monetary gamble task and for the status gamble task, because these were played independently in a fixed order and had different magnitudes and expected values, and thus were not entirely comparable. P values for regression coefficients were determined with Likelihood Ratio Tests. Reported estimates are odds ratios (OR) and</figDesc><table><row><cell>Wald 95% confidence intervals (CIs), and means are estimated marginal means unless otherwise</cell></row><row><cell>stated. Planned and post-hoc comparisons were obtained using emmeans, based on two-tailed tests</cell></row><row><cell>where no other statistical corrections (e.g., adjustments for multiple comparisons) were made. The</cell></row><row><cell>total sample broken down for each group: Testosterone (n=82) including high rank n=45 and low rank</cell></row><row><cell>n=37; Placebo (n=84) including high rank n=40, low rank n=44.</cell></row></table><note>Moderators Baseline cortisol, trait dominance, CAG-repeat and DAT1 polymorphisms were separately included in the model as described above, to explore whether they influenced the effect of testosterone on risk- taking depending on social status. Expected value of the gambles was included as predictor and random effect only, without interactions, to reduce model complexity, which was supported by model comparison (full model incl. interactions, c 2 (3) = 4.76, p=.199).</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 2</head><label>2</label><figDesc>, testosterone (vs. placebo) did not differentially influence risk preferences for monetary gambles, nor was this influenced by whether participants had a high and low rank (drug x rank, p &gt; .05,</figDesc><table /><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 2 .</head><label>2</label><figDesc>Results of generalized mixed effects models for Money and for Status, involving Drug (testosterone,</figDesc><table><row><cell cols="4">placebo), Rank (high, low) and Expected Value (EV)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell cols="3">Risk-taking for money (N=166)</cell><cell></cell><cell></cell><cell cols="3">Risk-taking for status (N=166)</cell><cell></cell><cell></cell></row><row><cell>Predictors</cell><cell>Odds</cell><cell>SE</cell><cell>95% CI</cell><cell>z</cell><cell>p</cell><cell>Odds</cell><cell>SE</cell><cell>95% CI</cell><cell>z</cell><cell>p</cell></row><row><cell></cell><cell>Ratios</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Ratios</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Intercept</cell><cell>0.29</cell><cell cols="4">0.26 [0.17, 0.48] -4.74 &lt;.001</cell><cell cols="4">0.16 0.21 [0.11, 0.25] -8.59</cell><cell>&lt;.001</cell></row><row><cell>Rank</cell><cell>0.52</cell><cell cols="3">0.24 [0.32, 0.84] -2.70</cell><cell>.007</cell><cell cols="4">0.73 0.18 [0.51, 1.04] -1.75</cell><cell>.081</cell></row><row><cell>Drug</cell><cell>0.88</cell><cell cols="3">0.24 [0.55, 1.41] -0.52</cell><cell>.602</cell><cell cols="4">1.21 0.18 [0.84, 1.73] 1.02</cell><cell>.305</cell></row><row><cell>Expected Value (EV)</cell><cell>7.31</cell><cell cols="4">0.14 [5.58, 9.56] 14.49 &lt;.001</cell><cell cols="4">1.16 0.01 [1.14, 1.19] 14.04</cell><cell>&lt;.001</cell></row><row><cell>Rank x Drug</cell><cell>1.22</cell><cell cols="3">0.24 [0.76, 1.96] 0.84</cell><cell>.399</cell><cell cols="4">1.63 0.18 [1.13, 2.33] 2.64</cell><cell>.008</cell></row><row><cell>Rank x EV</cell><cell>1.13</cell><cell cols="3">0.10 [0.94, 1.37] 1.29</cell><cell>.197</cell><cell cols="4">1.01 0.01 [1.00, 1.03] 1.76</cell><cell>.078</cell></row><row><cell>Drug x EV</cell><cell>1.00</cell><cell cols="3">0.10 [0.82, 1.20] -0.04</cell><cell>.967</cell><cell cols="4">1.00 0.01 [0.98, 1.01] -0.46</cell><cell>.649</cell></row><row><cell>Rank x Drug x EV</cell><cell>1.07</cell><cell cols="3">0.10 [0.89, 1.29] 0.70</cell><cell>.481</cell><cell cols="4">0.99 0.01 [0.98, 1.00] -1.31</cell><cell>.189</cell></row><row><cell>Marginal R 2 / Conditional R 2</cell><cell></cell><cell></cell><cell>0.594 / 0.910</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>0.671 / 0.895</cell><cell></cell><cell></cell></row><row><cell cols="11">Note: sum-to-zero contrasts were applied (i.e. effect coding). Testosterone and High rank were coded as 1.</cell></row><row><cell cols="3">Expected Value was centered at 0.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>Table S1 . Panel of loci and primer sets used for the typing of repeat length polymorphisms</head><label>S1</label><figDesc>Chromosome number and genomic location of targeted sequence (orientation provided in brackets) according to UCSC version hg38 (http://genome.ucsc.edu/) b The non-specific primer tail is underlined in Italics c The final primer concentrations in the reaction mix</figDesc><table><row><cell>Marker</cell><cell>Location a</cell><cell>Primer sequence 5'-3' b</cell><cell>Dye</cell><cell cols="2">Orientation Conc.(nM) c</cell></row><row><cell>AR(CAG)n</cell><cell cols="2">chrX:67545237-67545434(+) CGCGAAGTGATCCAGAACC</cell><cell cols="2">6-FAM forward</cell><cell>200</cell></row><row><cell></cell><cell></cell><cell>GTTTCTAGAACCATCCTCACCCTGCT</cell><cell></cell><cell>reverse</cell></row><row><cell cols="2">DAT1 VNTR chr5:1393559-1394008(-)</cell><cell>TGTGGTGTAGGGAACGGCCTGAGA</cell><cell cols="2">6-FAM forward</cell><cell>400</cell></row><row><cell></cell><cell></cell><cell>TGTTGGTCTGCAGGCTGCCTGCAT</cell><cell></cell><cell>reverse</cell></row><row><cell>a</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="1">Including baseline cortisol or DAT1 resulted in a marginal effect of rank (p=.081, p=.0506, respectively).</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p>We thank Isabelle Krol, Christina Fasching, Eric Förster, Katharina Hirning, Nace Mikus, Lisa Rosenberger, Sebastijan Veselic for assistance in data collection, Romana Raab (FDZ) for technical assistance in genotyping, and Igor Riecansky for medical support.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Open practices statement</head><p>The current design and analysis plans were not formally preregistered.</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>624</head><p>Continuous variables Expected value, baseline cortisol, trait dominance and CAG-repeat length were centered at 625 0.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Testosterone and Economic Risk Taking: A Review</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">L</forename><surname>Apicella</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Carré</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Dreber</surname></persName>
		</author>
		<idno type="DOI">10.1007/s40750-014-0020-2</idno>
		<ptr target="https://doi.org/10.1007/s40750-014-0020-2" />
	</analytic>
	<monogr>
		<title level="j">Adaptive Human Behavior and Physiology</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="358" to="385" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Salivary testosterone change following monetary wins and losses predicts future financial risk-taking</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">L</forename><surname>Apicella</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Dreber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Mollerstrom</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.psyneuen.2013.09.025</idno>
		<ptr target="https://doi.org/10.1016/j.psyneuen.2013.09.025" />
	</analytic>
	<monogr>
		<title level="j">Psychoneuroendocrinology</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="58" to="64" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Testosterone and human aggression: An evaluation of the challenge hypothesis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Archer</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neubiorev.2004.12.007</idno>
		<ptr target="https://doi.org/10.1016/j.neubiorev.2004.12.007" />
	</analytic>
	<monogr>
		<title level="j">Neuroscience and Biobehavioral Reviews</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="319" to="345" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Fitting Linear Mixed-Effects Models Using lme4</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Bates</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Mächler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Bolker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Walker</surname></persName>
		</author>
		<idno type="DOI">10.18637/jss.v067.i01</idno>
		<ptr target="https://doi.org/10.18637/jss.v067.i01" />
	</analytic>
	<monogr>
		<title level="j">Journal of Statistical Software</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="48" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Testosterone inhibits trust but promotes reciprocity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A S</forename><surname>Boksem</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">H</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Van Den Bergh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Van Son</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">T</forename><surname>Trautmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Roelofs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Sanfey</surname></persName>
		</author>
		<idno type="DOI">10.1177/0956797613495063</idno>
		<ptr target="https://doi.org/10.1177/0956797613495063" />
	</analytic>
	<monogr>
		<title level="j">Psychological Science</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="2306" to="2314" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Exogenous Testosterone Rapidly Increases Aggressive Behavior in Dominant and Impulsive Men</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Carré</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">N</forename><surname>Geniole</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">L</forename><surname>Ortiz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">M</forename><surname>Bird</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Videto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">L</forename><surname>Bonin</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.biopsych.2016.06.009</idno>
		<ptr target="https://doi.org/10.1016/j.biopsych.2016.06.009" />
	</analytic>
	<monogr>
		<title level="j">Biological Psychiatry</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="249" to="256" />
			<date type="published" when="2017" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Testosterone reactivity to competition and competitive endurance in men and women</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">V</forename><surname>Casto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Akinola</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">H</forename><surname>Mehta</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.yhbeh.2019.104665</idno>
		<ptr target="https://doi.org/10.1016/j.yhbeh.2019.104665" />
	</analytic>
	<monogr>
		<title level="j">Hormones and Behavior</title>
		<imprint>
			<date type="published" when="2020" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Cortisol and testosterone increase financial risk taking and may destabilize markets</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Cueva</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">E</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Spencer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Rani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Tempest</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">N</forename><surname>Tobler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Rustichini</surname></persName>
		</author>
		<idno type="DOI">10.1038/srep11206</idno>
		<ptr target="https://doi.org/10.1038/srep11206" />
	</analytic>
	<monogr>
		<title level="j">Scientific Reports</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">11206</biblScope>
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Dopaminergic and serotonergic activity in neostriatum and nucleus accumbens enhanced by intranasal administration of testosterone</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>De Souza Silva</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Mattern</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Topic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">E</forename><surname>Buddenberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Huston</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.euroneuro.2008.08.003</idno>
		<ptr target="https://doi.org/10.1016/j.euroneuro.2008.08.003" />
	</analytic>
	<monogr>
		<title level="j">European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="53" to="63" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Understanding overbidding: using the neural circuitry of reward to design economic auctions</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Delgado</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Schotter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">Y</forename><surname>Ozbay</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">A</forename><surname>Phelps</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1158860</idno>
		<ptr target="https://doi.org/10.1126/science.1158860" />
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="issue">5897</biblScope>
			<biblScope unit="page" from="1849" to="1852" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">The impact of sex hormone concentrations on decision-making in females and males</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Derntl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Pintzinger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Kryspin-Exner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Schöpf</surname></persName>
		</author>
		<idno type="DOI">10.3389/fnins.2014.00352</idno>
		<ptr target="https://doi.org/10.3389/fnins.2014.00352" />
	</analytic>
	<monogr>
		<title level="j">Frontiers in Neuroscience</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">352</biblScope>
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">The role of testosterone in social interaction</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Eisenegger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Haushofer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Fehr</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.tics.2011.04.008</idno>
		<ptr target="https://doi.org/10.1016/j.tics.2011.04.008" />
	</analytic>
	<monogr>
		<title level="j">Trends in Cognitive Sciences</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="263" to="271" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Testosterone and androgen receptor gene polymorphism are associated with confidence and competitiveness in men</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Eisenegger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Kumsta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Naef</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Gromoll</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Heinrichs</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.yhbeh.2016.09.011</idno>
		<ptr target="https://doi.org/10.1016/j.yhbeh.2016.09.011" />
	</analytic>
	<monogr>
		<title level="j">Hormones and Behavior</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="93" to="102" />
			<date type="published" when="2017" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Prejudice and truth about the effect of testosterone on human bargaining behaviour</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Eisenegger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Naef</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Snozzi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Heinrichs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Fehr</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature08711</idno>
		<ptr target="https://doi.org/10.1038/nature08711" />
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">463</biblScope>
			<biblScope unit="issue">7279</biblScope>
			<biblScope unit="page" from="356" to="359" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Pharmacokinetics of testosterone and estradiol gel preparations in healthy young men</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Eisenegger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Von Eckardstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Fehr</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Von Eckardstein</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.psyneuen.2012.05.018</idno>
		<ptr target="https://doi.org/10.1016/j.psyneuen.2012.05.018" />
	</analytic>
	<monogr>
		<title level="j">Psychoneuroendocrinology</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="171" to="178" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Relative status regulates risky decision making about resources in men: evidence for the co-evolution of motivation and cognition</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Ermer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Cosmides</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Tooby</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.evolhumbehav.2007.11.002</idno>
		<ptr target="https://doi.org/10.1016/j.evolhumbehav.2007.11.002" />
	</analytic>
	<monogr>
		<title level="j">Evolution and Human Behavior</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="106" to="118" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Why social status matters for understanding the interrelationships between testosterone, economic risk-taking, and gender</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">R</forename><surname>Fisk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">J</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Overton</surname></persName>
		</author>
		<idno type="DOI">10.1111/soc4.12452</idno>
		<ptr target="https://doi.org/10.1111/soc4.12452" />
	</analytic>
	<monogr>
		<title level="j">Sociology Compass</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">3</biblScope>
			<date type="published" when="2017" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Human social neuroendocrinology: Review of the rapid effects of testosterone</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">N</forename><surname>Geniole</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Carré</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.yhbeh.2018.06.001</idno>
		<ptr target="https://doi.org/10.1016/j.yhbeh.2018.06.001" />
	</analytic>
	<monogr>
		<title level="j">Hormones and Behavior</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="192" to="205" />
			<date type="published" when="2018-02" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Using a Psychopharmacogenetic Approach To Identify the Pathways Through Whichand the People for Whom-Testosterone Promotes Aggression</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">N</forename><surname>Geniole</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">L</forename><surname>Procyshyn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Marley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">L</forename><surname>Ortiz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">M</forename><surname>Bird</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">L</forename><surname>Marcellus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Carré</surname></persName>
		</author>
		<idno type="DOI">10.1177/0956797619826970</idno>
		<ptr target="https://doi.org/10.1177/0956797619826970" />
	</analytic>
	<monogr>
		<title level="j">Psychological Science</title>
		<imprint>
			<biblScope unit="page" from="1" to="14" />
			<date type="published" when="2019" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">The influence of high-normal testosterone levels on risk-taking in healthy males in a 1-week letrozole administration study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">E</forename><surname>Goudriaan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Lapauw</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Ruige</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Feyen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Kaufman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Brand</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Vingerhoets</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.psyneuen.2010.04.005</idno>
		<ptr target="https://doi.org/10.1016/j.psyneuen.2010.04.005" />
	</analytic>
	<monogr>
		<title level="j">Psychoneuroendocrinology</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1416" to="1421" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Genotype Influences In Vivo Dopamine Transporter Availability in Human Striatum</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Heinz</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0893-133X(99</idno>
		<ptr target="https://doi.org/10.1016/S0893-133X(99" />
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="99" to="107" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Effects of exogenous testosterone on the ventral striatal BOLD response during reward anticipation in healthy women</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">J</forename><surname>Hermans</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">A</forename><surname>Bos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Ossewaarde</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">F</forename><surname>Ramsey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Fernandez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Van Honk</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuroimage.2010.04.019</idno>
		<ptr target="https://doi.org/10.1016/j.neuroimage.2010.04.019" />
	</analytic>
	<monogr>
		<title level="j">Neuroimage</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="277" to="283" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Neural mechanisms underlying context-dependent shifts in risk preferences</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Losecaat</forename><surname>Vermeer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">B</forename><surname>Boksem</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A S</forename><surname>Sanfey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NeuroImage</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="355" to="363" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title/>
		<idno type="DOI">10.1016/j.neuroimage.2014.09.054</idno>
		<ptr target="https://doi.org/10.1016/j.neuroimage.2014.09.054" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Exogenous testosterone increases status-seeking motivation in men with unstable low social status</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Losecaat</forename><surname>Vermeer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">B</forename><surname>Krol</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Gausterer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Eisenegger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Lamm</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.psyneuen.2019.104552</idno>
		<ptr target="https://doi.org/10.1016/j.psyneuen.2019.104552" />
	</analytic>
	<monogr>
		<title level="j">Psychoneuroendocrinology</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<date type="published" when="2020" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Competition, testosterone, and adult neurobehavioral plasticity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Losecaat</forename><surname>Vermeer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">B</forename><surname>Riečanský</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Eisenegger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename></persName>
		</author>
		<idno type="DOI">10.1016/bs.pbr.2016.05.004</idno>
		<ptr target="https://doi.org/10.1016/bs.pbr.2016.05.004" />
	</analytic>
	<monogr>
		<title level="m">Progress in Brain Research</title>
		<imprint>
			<date type="published" when="2016" />
			<biblScope unit="page" from="213" to="238" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Testosterone and dominance in men</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Mazur</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Booth</surname></persName>
		</author>
		<ptr target="http://www.ncbi.nlm.nih.gov/pubmed/10097017" />
	</analytic>
	<monogr>
		<title level="j">The Behavioral and Brain Sciences</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="353" to="363" />
			<date type="published" when="1998" />
		</imprint>
	</monogr>
	<note>discussion 363-97</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Testosterone change after losing predicts the decision to compete again</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">H</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Josephs</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.yhbeh.2006.07.001</idno>
		<ptr target="https://doi.org/10.1016/j.yhbeh.2006.07.001" />
	</analytic>
	<monogr>
		<title level="j">Hormones and Behavior</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="684" to="692" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Exogenous testosterone in women enhances and inhibits competitive decision-making depending on victory-defeat experience and trait dominance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">H</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Son</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Van</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">M</forename><surname>Welker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Prasad</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">G</forename><surname>Sanfey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Smidts</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Roelofs</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.psyneuen.2015.07.004</idno>
		<ptr target="https://doi.org/10.1016/j.psyneuen.2015.07.004" />
	</analytic>
	<monogr>
		<title level="j">Psychoneuroendocrinology</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="224" to="236" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Testosterone and cortisol jointly modulate risk-taking</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">H</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">M</forename><surname>Welker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Zilioli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Carré</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.psyneuen.2015.02.023</idno>
		<ptr target="https://doi.org/10.1016/j.psyneuen.2015.02.023" />
	</analytic>
	<monogr>
		<title level="j">Psychoneuroendocrinology</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="88" to="99" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<title level="m" type="main">The Bull of Wall Street: Experimental Analysis of Testosterone and Asset Trading. Management Science, mnsc</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Nadler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Jiao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">J</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Alexander</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Zak</surname></persName>
		</author>
		<idno type="DOI">10.1287/mnsc.2017.2836</idno>
		<ptr target="https://doi.org/10.1287/mnsc.2017.2836" />
		<imprint>
			<date type="published" when="2017" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">16-Persönlichkeits-Faktoren-Test. Revision (16 PF-R)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">A</forename><surname>Schneewind</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Graf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Deutsche Ausgabe des 16 PF</title>
		<imprint>
			<publisher>Huber</publisher>
			<date type="published" when="1998" />
			<biblScope unit="page" from="1" to="133" />
		</imprint>
	</monogr>
	<note>5th ed.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The role of testosterone and estrogen in consumer behavior and social &amp; economic decision making: A review</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Stanton</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.yhbeh.2016.11.006</idno>
		<ptr target="https://doi.org/10.1016/j.yhbeh.2016.11.006" />
	</analytic>
	<monogr>
		<title level="j">Hormones and Behavior</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="155" to="163" />
			<date type="published" when="2017" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Low-and high-testosterone individuals exhibit decreased aversion to economic risk</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Stanton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><forename type="middle">A</forename><surname>Mullette-Gillman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">E</forename><surname>Mclaurin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">M</forename><surname>Kuhn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">S</forename><surname>Labar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">L</forename><surname>Platt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">A</forename><surname>Huettel</surname></persName>
		</author>
		<idno type="DOI">10.1177/0956797611401752</idno>
		<ptr target="https://doi.org/10.1177/0956797611401752" />
	</analytic>
	<monogr>
		<title level="j">Psychological Science</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="447" to="453" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">The framing of decisions and the psychology of choice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Tversky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Kahneman</surname></persName>
		</author>
		<ptr target="http://www.ncbi.nlm.nih.gov/pubmed/7455683" />
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="issue">4481</biblScope>
			<biblScope unit="page" from="453" to="458" />
			<date type="published" when="1981" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Testosterone shifts the balance between sensitivity for punishment and reward in healthy young women</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Van Honk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J L G</forename><surname>Schutter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">J</forename><surname>Hermans</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Putman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Tuiten</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Koppeschaar</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.psyneuen.2003.08.007</idno>
		<ptr target="https://doi.org/10.1016/j.psyneuen.2003.08.007" />
	</analytic>
	<monogr>
		<title level="j">Psychoneuroendocrinology</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="937" to="943" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Perceived and experimentally manipulated status moderates the relationship between facial structure and risk-taking</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">M</forename><surname>Welker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">M M</forename><surname>Goetz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Carré</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.evolhumbehav.2015.03.006</idno>
		<ptr target="https://doi.org/10.1016/j.evolhumbehav.2015.03.006" />
	</analytic>
	<monogr>
		<title level="j">Evolution and Human Behavior</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="423" to="429" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Taking risks for personal gain: An investigation of self-construal and testosterone responses to competition</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">M</forename><surname>Welker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">R K</forename><surname>Roy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Geniole</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Kitayama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Carré</surname></persName>
		</author>
		<idno type="DOI">10.1080/17470919.2017.1407822</idno>
		<ptr target="https://doi.org/10.1080/17470919.2017.1407822" />
	</analytic>
	<monogr>
		<title level="j">Social Neuroscience</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="99" to="113" />
			<date type="published" when="2019" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Single dose testosterone administration reduces loss chasing in healthy females</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Qu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Eisenegger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Zhou</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.psyneuen.2016.05.005</idno>
		<ptr target="https://doi.org/10.1016/j.psyneuen.2016.05.005" />
	</analytic>
	<monogr>
		<title level="j">Psychoneuroendocrinology</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="54" to="57" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">A randomized trial of the effect of estrogen and testosterone on economic behavior</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Zethraeus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Kocoska-Maras</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Ellingsen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Von Schoultz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">L</forename><surname>Hirschberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Johannesson</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0812757106</idno>
		<ptr target="https://doi.org/10.1073/pnas.0812757106" />
	</analytic>
	<monogr>
		<title level="m">Proceedings of the National Academy of Sciences of the United States of America</title>
		<meeting>the National Academy of Sciences of the United States of America</meeting>
		<imprint>
			<date type="published" when="2009" />
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="6535" to="6538" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">The CAG repeat polymorphism within the androgen receptor gene and maleness1</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Zitzmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Nieschlag</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1365-2605.2003.00393.x</idno>
		<ptr target="https://doi.org/10.1046/j.1365-2605.2003.00393.x" />
	</analytic>
	<monogr>
		<title level="j">International Journal of Andrology</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="76" to="83" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">DAT1 polymorphism determines L-DOPA effects on learning about others&apos; prosociality</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">References</forename><surname>Eisenegger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Pedroni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Rieskamp</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Zehnder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Ebstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Fehr</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Knoch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0067820</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0067820" />
	</analytic>
	<monogr>
		<title level="j">PloS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Genotype Influences In Vivo Dopamine Transporter Availability in Human Striatum</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Heinz</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0893-133X(99</idno>
		<ptr target="https://doi.org/10.1016/S0893-133X(99" />
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="99" to="107" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Theoretical analysis of a multidimensional mood questionnaire (MDBF)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Steyer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Schwenkmezger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Notz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Eid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Testtheoretische Analysen Des Mehrdimensionalen Befindlichkeitsfragebogen (MDBF)</title>
		<imprint>
			<date type="published" when="1994" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
